En direct

Géraldine Guasch (CRCM) - Publication dans Nature Communications -

08 2019 Nature communications

Emerging epigenomic landscapes of pancreatic cancer in the era of precision medicine.

Auteurs

Lomberk G, Dusetti N, Iovanna J, Urrutia R

Résumé

Genetic studies have advanced our understanding of pancreatic cancer at a mechanistic and translational level. Genetic concepts and tools are increasingly starting to be applied to clinical practice, in particular for precision medicine efforts. However, epigenomics is rapidly emerging as a promising conceptual and methodological paradigm for advancing the knowledge of this disease. More importantly, recent studies have uncovered potentially actionable pathways, which support the prediction that future trials for pancreatic cancer will involve the vigorous testing of epigenomic therapeutics. Thus, epigenomics promises to generate a significant amount of new knowledge of both biological and medical importance.

Lire l‘article

Documents à télécharger